Patent details

EP3102609 Title: METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3102609
WO Application Number:
US2015014520
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP15746399.3
WO Publication Number:
WO2015120096
EPO Publication Language:
English
SPC Number:
301320
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
04/02/2015
Grant date:
28/08/2024
EP Publication Date:
14/12/2016
WO Publication Date:
13/08/2015
Claims Translations Received Date:
Claims Translation B1 Received Date:
20/09/2024
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
28/08/2024
EP B1 Publication Date:
28/08/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
03/02/2035
Lapsed By Expiration Date:
Patent Validated Date:
26/09/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
28/08/2024
 
 

 

Name:
The United States of America, as Represented by The Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive Suite 700, MSC 7788, 20892-7788, Bethesda, Maryland , United States of America (US)

From:
28/08/2024
 
 

 

Name:
Kite Pharma, Inc.
Address:
2400 Broadway, 90404, Santa Monica, CA, United States of America (US)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
25/09/2024
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
BETTER, Marc
Address:
Santa Monica, California 90404, United States of America (US)

2

Name:
FELDMAN, Steven A.
Address:
Bethesda, Maryland 20892-1201, United States of America (US)

3

Name:
ROSENBERG, Steven A.
Address:
Bethesda, Maryland 20892-1201, United States of America (US)

Priority

Priority Patent Number:
201461935833 P
Priority Date:
04/02/2014
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C12N 5/0783; A61K 39/00; A61K 38/17; C07K 14/725; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
40/24
Publication date:
02/10/2024
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
35/24
Publication date:
28/08/2024
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202435
Publication date:
28/08/2024
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
28/02/2026
Annual Fee Number:
12
Annual Fee Amount:
600 Euro
Last Annual Payment Date:
14/12/2024
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
500 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
25/09/2024 Outgoing Correspondence Letter no formal defects 1 PDF /3/0/2/3/3/0801033203/docs/ep15746399.3_0_623878l271.pdf
20/09/2024 Claims First filed claims 2 PDF /3/0/2/3/3/0801033203/docs/ep15746399.3_1_claims20240920084526244.pdf